E0924G is an orally active activator for PPARδ with EC 50 of 2.82 μM. E0924G promotes the upregulation of osteoprotegerin (OPG) with an EC 50 of 0.29 μM. E0924G reduces RANKL-induced osteoclast differentiation and inhibites F-actin ring formation in RAW264.7 macrophages. E0924G regulates the bone density and bone loss in ovariectomized (OVX) and age-related osteoporosis models [1].
References:
[1]. Li Y, et al., The novel small molecule E0924G dually regulates bone formation and bone resorption through activating the PPARδ signaling pathway to prevent bone loss in ovariectomized rats and senile mice. Bioorg Chem. 2024 Jun;147:107364.
References:
[1]. Li Y, et al., The novel small molecule E0924G dually regulates bone formation and bone resorption through activating the PPARδ signaling pathway to prevent bone loss in ovariectomized rats and senile mice. Bioorg Chem. 2024 Jun;147:107364.
















